Monday, October 26, 2026 · Daily editionET --:--:--

Finished

CorPath™ 200: Robotically-Assisted Percutaneous Coronary Intervention (PCI)

NCT01076036 · Siemens Healthineers Endovascular Robotics, Inc. · Updated 7 Sept 2015

What is being tested
CorPath 200; CorPath 200
For
Coronary Artery Disease
Kind of study
Tests a treatment or device on volunteers. Phase 2.
Who can join
Ages 18 years and older. About 8 people. The full rules are on the registry page.
Where
Colombia
When
Starts or started Feb 2010, ends May 2010. Registered 25 Feb 2010.
Results
Posted on the registry on 7 Sept 2015.

In the researchers' words

An open-label, prospective, single-arm study is designed to evaluate safety, clinical and technical efficacy of the CorPath 200 System in delivery and manipulation of the coronary guide wires and balloon/stent systems for use in robotically-assisted, percutaneous coronary intervention (PCI) procedures.
ClinicalTrials.gov, NCT01076036

Sites

  • CORBIC Cardio-Neuro-Vascular InstituteMedellín, Colombia